SMITH ASSET MANAGEMENT GROUP LP - GALENA BIOPHARMA INC ownership

GALENA BIOPHARMA INC's ticker is GALEXXXX and the CUSIP is 363256108. A total of 92 filers reported holding GALENA BIOPHARMA INC in Q2 2014. The put-call ratio across all filers is 0.47 and the average weighting 0.0%.

Quarter-by-quarter ownership
SMITH ASSET MANAGEMENT GROUP LP ownership history of GALENA BIOPHARMA INC
ValueSharesWeighting
Q3 2014$1,137,000
-32.9%
552,160
-0.3%
0.04%
-33.3%
Q2 2014$1,695,000554,0800.06%
Other shareholders
GALENA BIOPHARMA INC shareholders Q2 2014
NameSharesValueWeighting ↓
Spark Investment Management LLC 308,500$462,0000.08%
Perceptive Advisors 200,000$302,0000.02%
DUMONT & BLAKE INVESTMENT ADVISORS LLC 29,675$45,0000.02%
EXANE DERIVATIVES 100,000$150,995,0000.02%
PIPER SANDLER & CO. 20,000$30,0000.02%
Alyeska Investment Group, L.P. 530,000$801,0000.01%
COMPTON CAPITAL MANAGEMENT INC /RI 15,000$23,0000.01%
SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) 13,350$20,0000.01%
GROUP ONE TRADING, L.P. 458,952$693,0000.01%
WOLVERINE ASSET MANAGEMENT LLC 1,605$388,0000.01%
View complete list of GALENA BIOPHARMA INC shareholders